Bioventus (US:BVS) Globenewswireยท2025-10-28 11:00Core Viewpoint - Bioventus Inc. will report its financial results for Q3 of fiscal year 2025 on November 4, 2025, and will host a conference call to discuss these results and provide a business update [1]. Financial Reporting - The financial results will be announced before the market opens on November 4, 2025 [1]. - A conference call is scheduled for 8:30 a.m. Eastern Time on the same day to discuss the results [1]. Conference Call Participation - Participants can join the conference call by dialing 1-833-636-0497 and referencing the Bioventus Inc. Conference Call [2]. - A live webcast of the call will be available on the Company's Investor Relations website, with an archive for replay until November 3, 2026 [2]. Company Overview - Bioventus is a global leader in innovations for active healing, providing clinically proven and cost-effective products that aid in quick and safe healing [3]. - The company's mission focuses on helping patients resume active lives through its offerings in Pain Treatments, Restorative Therapies, and Surgical Solutions [3]. - Bioventus emphasizes high quality standards, evidence-based medicine, and strong ethical behavior, positioning itself as a trusted partner for physicians worldwide [3].